FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Major Pharmaceuticals Divalproex Sodium Extended-Release Tablets Recall

DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS, USP Tablets, 250 mg, 100 count-unit dose ca…

MAJOR PHARMACEUTICALS · Livonia, MI

Risk level
Class II
Reported by FDA
Aug 7, 2019
Recall ID
D-1583-2019
Check your lot numberHow we source this data

Summary

Major Pharmaceuticals recalled Divalproex Sodium Extended-Release Tablets starting Apr 24, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1583-2019 on Aug 7, 2019. Reason: cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations. Status: Terminated.

Why it was recalled

cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.

Product description

DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS, USP Tablets, 250 mg, 100 count-unit dose carton, RX only, Manufactured by Dr. Reddy's Laboratories Ltd. Bachupally - 500 090 India. Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152. NDC # 0904-6363-61.

Lot numbers, UPCs & expiration codes

Lot# M02250 EXP 10/2020.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1583-2019
Classification
Class II
Status
Terminated
Recall initiated
Apr 24, 2019
FDA report date
Aug 7, 2019
Quantity
828 100-count unit dose cartons
Recall type
N/A
Recalling firm
MAJOR PHARMACEUTICALS

Original FDA data

Every field from FDA enforcement report D-1583-2019, exactly as published.

Show all FDA fields
City
Livonia
State
MI
Status
Terminated
Country
United States
Event ID
83460
Address
17177 N Laurel Park Dr
Code information
Lot# M02250 EXP 10/2020.
Postal code
48152-2693
Report date
Aug 7, 2019
Product type
Drugs
Recall number
D-1583-2019
Classification
Class II
Recalling firm
MAJOR PHARMACEUTICALS
Product quantity
828 100-count unit dose cartons
Termination date
Jul 16, 2020
Reason for recall
cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.
Product description
DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS, USP Tablets, 250 mg, 100 count-unit dose carton, RX only, Manufactured by Dr. Reddy's Laboratories Ltd. Bachupally - 500 090 India. Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152. NDC # 0904-6363-61.
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 24, 2019
Center classification date
Aug 1, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1583-2019, published Aug 7, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls